Adicet Historical Income Statement
| ACET Stock | USD 1.95 0.08 3.94% |
Historical analysis of Adicet Bio income statement accounts such as Selling General Administrative of 34.7 M, Total Revenue of 0.0 or Other Operating Expenses of 230.1 M can show how well Adicet Bio performed in making a profits. Evaluating Adicet Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Adicet Bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Adicet Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Adicet Bio is a good buy for the upcoming year.
Adicet |
About Adicet Income Statement Analysis
Adicet Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Adicet Bio shareholders. The income statement also shows Adicet investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Adicet Bio Income Statement Chart
Adicet Bio Income Statement is one of the three primary financial statements used for reporting Adicet's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Adicet Bio revenue and expense. Adicet Bio Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Adicet Bio's Selling General Administrative is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 230.1 M in 2024, whereas Total Revenue is likely to drop 0.00 in 2024. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Adicet Bio. It is also known as Adicet Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Adicet Bio income statement and represents the costs associated with goods and services Adicet Bio provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Adicet Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Adicet Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.At this time, Adicet Bio's Selling General Administrative is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 230.1 M in 2024, whereas Total Revenue is likely to drop 0.00 in 2024.
| 2023 | 2024 (projected) | Total Operating Expenses | 126.5M | 69.4M | Cost Of Revenue | 6.1M | 5.8M |
Adicet Bio income statement Correlations
Click cells to compare fundamentals
Adicet Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Adicet Bio income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 4.5M | (168K) | (515K) | 2.8M | 6.1M | 4.2M | |
| Selling General Administrative | 8.7M | 22.8M | 22.2M | 26.3M | 26.5M | 34.7M | |
| Total Revenue | 8.2M | 995K | 17.9M | 9.7M | 25.0M | 0.0 | |
| Gross Profit | 870K | 17.9M | 9.7M | 20.0M | (6.1M) | (5.8M) | |
| Other Operating Expenses | 32.4M | 57.1M | 71.2M | 97.5M | 132.6M | 230.1M | |
| Operating Income | (31.4M) | (39.2M) | (61.4M) | (72.6M) | (132.6M) | (125.9M) | |
| Ebit | (31.4M) | (39.2M) | (61.4M) | (72.6M) | (132.6M) | (125.9M) | |
| Research Development | 23.7M | 34.3M | 48.9M | 71.2M | 106.0M | 111.3M | |
| Ebitda | (26.9M) | (39.4M) | (61.9M) | (69.7M) | (126.5M) | (120.2M) | |
| Total Operating Expenses | 32.4M | 57.1M | 71.2M | 97.5M | 126.5M | 69.4M | |
| Income Before Tax | (28.1M) | (39.5M) | (62.1M) | (69.8M) | (142.7M) | (135.5M) | |
| Total Other Income Expense Net | 3.3M | (302K) | (691K) | 2.8M | (10.1M) | (9.6M) | |
| Net Income | (28.1M) | (36.7M) | (62.0M) | (67.0M) | (142.7M) | (135.5M) | |
| Income Tax Expense | 19K | (2.8M) | (125K) | (2.8M) | (2.5M) | (2.4M) |
Pair Trading with Adicet Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adicet Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adicet Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Adicet Stock
| 0.73 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
Moving against Adicet Stock
| 0.75 | ELMD | Electromed | PairCorr |
| 0.74 | HIMS | Hims Hers Health Financial Report 13th of May 2024 | PairCorr |
| 0.69 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.63 | HOLX | Hologic Financial Report 6th of May 2024 | PairCorr |
| 0.52 | BAX | Baxter International Financial Report 25th of April 2024 | PairCorr |
The ability to find closely correlated positions to Adicet Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adicet Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adicet Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adicet Bio to buy it.
The correlation of Adicet Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adicet Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adicet Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adicet Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adicet Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.Note that the Adicet Bio information on this page should be used as a complementary analysis to other Adicet Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Adicet Stock analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Adicet Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.31) | Quarterly Revenue Growth (1.00) | Return On Assets (0.31) | Return On Equity (0.62) |
The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.